Dediabetes Logo
Preguntas
Respuestas publicadas conectadas con evidencia
Referencia clínica
Dossieres detallados de intervenciones y resultados
Investigacion reciente
Estudios mas recientes
Acerca de
Cómo funciona deDiabetes
Configuracion
Entrar / Unirse

Insulin Therapies for Diabetes: Evidence and Outcomes

Ver informe de evidencia

Evidence on outcomes studied for Insulin Therapies

Evidence related to insulin therapies in diabetes studies.

Crea tu Evidence Workspace

Guarda evidencia sobre los temas que te importan.

37
Studies
100
Evidence Pairs
Moderate Evidence
Evidence Strength: 62/100
Evidence Intelligence™

Evidence Summary

A structured summary of where the evidence is strongest, mixed, or still emerging.

Executive Summary

Insulin Therapies evidence appears to center on HbA1c.

Among 37 indexed studies and 4 interventions, the strongest signals are summarized from the available evidence. HbA1c appears to be one of the clearer current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.
Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

HbA1c appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies
Evidence basis: 13 evidence pairs - 28 studies

Why this appears here

Strong evidenceGenerally consistentPositive effect signalMultiple RCTsConsistent results
HbA1c
18 studies
EvidenceScore™
85/100
ConsistencyScore™
63/100
Time in range
7 studies
EvidenceScore™
82/100
ConsistencyScore™
59/100

Evidence Snapshot

37
Studies
4
Interventions
87
Outcomes
7
Strong evidence signals
3
Mixed evidence areas

Key Findings

Key patterns and insights identified across the research landscape

Moderate positive signal

HbA1c

Across 8 studies, Insulin therapy shows a moderate positive signal for HbA1c.

8 studies
EvidenceScore™: 85.20192307692308/100
View supporting studies
Moderate positive signal

Time in range

Across 5 studies, Insulin therapy shows a moderate positive signal for Time in range.

5 studies
EvidenceScore™: 81.76923076923077/100
View supporting studies
Moderate positive signal

Glucose iAUC (OGTT)

Across 4 studies, Insulin therapy shows a moderate positive signal for Glucose iAUC (OGTT).

4 studies
EvidenceScore™: 79/100
View supporting studies
Moderate positive signal

HbA1c

Across 3 studies, Insulin degludec shows a consistent moderate positive signal for HbA1c.

3 studies
EvidenceScore™: 79/100
View supporting studies
Strong positive signal

Total daily insulin dose

Across 3 studies, Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) shows a consistent strong positive signal for Total daily insulin dose.

3 studies
EvidenceScore™: 79/100
View supporting studies

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

HbA1c is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

HbA1c
Time in range
HbA1c
18 studies
EvidenceScore™
85/100
ConsistencyScore™
63/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results PresentNegative Results Present
Evidence basis: 14 evidence pairs - 29 studies
View supporting studies
Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Fasting Plasma Glucose (FPG) may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

Fasting Plasma Glucose (FPG)
Glucose iAUC (OGTT)
Fasting Plasma Glucose (FPG)
4 studies
EvidenceScore™
79/100
ConsistencyScore™
100/100

Why this appears here

Positive effect signalLimited study volume
Evidence basis: 6 evidence pairs - 12 studies
View supporting studies

Explore the Evidence

The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.

Preguntas respondidas por la evidencia

What outcomes has Insulin Therapies been studied for?

HbA1c, Time in range, and Total daily insulin dose are among the most studied areas in relation to Insulin Therapies.

Emerging Evidence · Consistency cannot yet be determined from the available evidence. · 37 studies · 37 RCTs

The evidence includes both beneficial and harmful or worsening results.

View top evidence signals ↓
  1. HbA1c · Strong · 18 studies
  2. Time in range · Strong · 7 studies
  3. Total daily insulin dose · Strong · 6 studies

Do Insulin Therapies lower HbA1c?

Insulin Therapies may lower HbA1c.

Strong Evidence · Results are generally consistent across studies. · 18 studies · 18 RCTs

View top evidence signals ↓
  1. HbA1c · Strong · 18 studies

Which outcomes have the strongest evidence for Insulin Therapies?

HbA1c, Time in range, and Total daily insulin dose have the strongest available evidence signals for Insulin Therapies.

Strong Evidence · Results are consistent across studies. · 27 studies · 27 RCTs

The evidence includes both beneficial and harmful or worsening results.

View top evidence signals ↓
  1. HbA1c · Strong · 18 studies
  2. Time in range · Strong · 7 studies
  3. Total daily insulin dose · Strong · 6 studies

Where does Insulin Therapies need more research?

Percentage of blood glucose measurements within target range of 3.9–7.8 mmol/L, Diabetes distress scores, and Time to glycemic target need more research in relation to Insulin Therapies.

Moderate Evidence · Results are mixed and should be interpreted cautiously. · 9 studies · 9 RCTs

The evidence includes both beneficial and harmful or worsening results.

View top evidence signals ↓
  1. Percentage of blood glucose measurements within target range of 3.9–7.8 mmol/L · Moderate · 2 studies
  2. Time to glycemic target · Moderate · 2 studies
  3. Systolic blood pressure · Moderate · 2 studies

How does Insulin Therapies compare across studied outcomes?

HbA1c, Time in range, and Total daily insulin dose have available evidence for Insulin Therapies, but the comparison requires review of the underlying studies.

Strong Evidence · Results are consistent across studies. · 27 studies · 27 RCTs

The evidence includes both beneficial and harmful or worsening results.

View top evidence signals ↓
  1. HbA1c · Strong · 18 studies
  2. Time in range · Strong · 7 studies
  3. Total daily insulin dose · Strong · 6 studies
Browse all questions about Insulin Therapies

Overall Evidence Signals

Among 37 indexed studies and 4 interventions, the strongest signals are summarized from the available evidence. HbA1c appears to be one of the clearer current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.

Evidence Relationships

Explore the intervention-outcome relationships with the strongest supporting evidence for Insulin Therapies.

10 strong relationships, ranked by available evidence

View every intervention-outcome relationship included in this topic.

Select any relationship to review its supporting studies.

Studies evaluating Insulin Therapies

Studies connected to this intervention in the evidence record.

Click outcomes and interventions to filter Evidence Explorer when links are available.

Continue exploring

Related evidence briefs

Hypoglycemia

Evidence Tracker

Track Insulin Therapies for Diabetes: Evidence and Outcomes evidence

Save this evidence topic and revisit it as new studies are added.